InduPro
PrivateLast Round
Series B
Aug 12, 2026
Total Funding Raised
$162M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
InduPro operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Series B round in August 2026.
InduPro is a biotechnology company that develops innovative therapeutics by manipulating protein pairings to create new signaling pathways and logic gates at the cell surface.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InduPro Comparables
Compare InduPro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpiBiologics | 83% | |
| Normunity | 83% | |
| Stipple Bio | 81% |
For institutional investors. Book with your work email.
InduPro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 12, 2026 | ||||
| Corporate Funding | Jan 7, 2026 | ||||
| Corporate Funding | Dec 10, 2025 | ||||
| Series A | Jun 13, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InduPro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series A |
| Vida Ventures | Series B, Series A |
| The Chernin Group | Series A |
| Solasta Ventures | Series B |
| Emerson Collective | Series B, Series A |
| Euclidean Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 70% MoM, reaching 2K.
- Aug 12, 2026
$77M round led by The Column Group.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 14, 2026
On Aug 14th '26, InduPro, Inc., which has operations in Washington and Massachusetts, is developing drugs based on the spatial relationships between proteins on the surface of cells.
For institutional investors. Book with your work email.
InduPro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InduPro's valuation, stock price, and market status.
Is InduPro a public or private company?
InduPro is a private company.
What is the current stock price of InduPro?
InduPro is a private company, so its shares have no public market price. Caplight tracks InduPro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InduPro worth (valuation)?
Valuation information for InduPro is not publicly available.
Can I buy InduPro stock?
InduPro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InduPro's last funding round?
InduPro's most recent funding round was Series B on August 12, 2026.
Who are the main investors in InduPro?
Key investors in InduPro include The Column Group, Vida Ventures, The Chernin Group.
Will InduPro IPO soon?
No public IPO plans have been announced for InduPro.
How can I track InduPro secondary market activity?
Caplight tracks bids, offers, and trades in InduPro's shares on secondary markets.